Showing results (201-210 of 496) with videos related to

Sort By:
Pageof 50
Journal of Virology|November 15, 2024
Protective threshold of a potent neutralizing Zika virus monoclonal antibody in rhesus macaquesJoseph P Nkolola, David Hope, Ruoran Guan, et al.
Nature Communications|November 26, 2021
Functional convalescent plasma antibodies and pre-infusion titers shape the early severe COVID-19 immune responseJonathan D Herman, Chuangqi Wang, Carolin Loos, et al.
Medrxiv : the Preprint Server for Health Sciences|March 24, 2021
Functional Antibodies in COVID-19 Convalescent PlasmaJonathan D Herman, Chuangqi Wang, Carolin Loos, et al.
The Journal of Clinical Investigation|October 4, 2011
A high-throughput single-cell analysis of human CD8⁺ T cell functions reveals discordance for cytokine secretion and cytolysisNavin Varadarajan, Boris Julg, Yvonne J Yamanaka, et al.
Blood|May 12, 2009
Identification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: effect of mutagenesis on FX interactions and gene transferRaul Alba, Angela C Bradshaw, Alan L Parker, et al.
Biorxiv : the Preprint Server for Biology|August 20, 2025
Longitudinal transcriptomic analysis of SIV-infected rhesus macaques reveals peripheral immune dynamics throughout untreated SIV infection and long-term antiretroviral therapySarah L Quinn, Micayla George, John D Ventura, et al.
AIDS Research and Human Retroviruses|May 27, 2014
The immune space: a concept and template for rationalizing vaccine developmentAmapola Manrique, Elizabeth Adams, Dan H Barouch, et al.
The Journal of Clinical Investigation|July 27, 2021
Natural killer cell immunosuppressive function requires CXCR3-dependent redistribution within lymphoid tissuesAyad Ali, Laura M Canaday, H Alex Feldman, et al.
Biorxiv : the Preprint Server for Biology|November 14, 2023
Last in first out: SIV proviruses seeded later in infection are harbored in short-lived CD4+ T cellsNarmada Sambaturu, Emily J Fray, Fengting Wu, et al.
Journal of Virology|October 9, 2023
Mosaic HIV-1 vaccination induces anti-viral CD8+ T cell functionality in the phase 1/2a clinical trial APPROACHJanine van Duijn, Daniel Stieh, Natalia Fernandez, et al.
Pageof 50